332 related articles for article (PubMed ID: 34650912)
1. Factors Associated With the Discussion of Fertility Preservation in a Cohort of 1,357 Young Breast Cancer Patients Receiving Chemotherapy.
Hours A; Toussaint A; De Castelbajac V; Sautter C; Borghese J; Frank S; Coussy F; Laas E; Grandal B; Dumas E; Daoud E; Guerin J; Balezeau T; Feron JG; Fourchotte V; Kirova Y; Lerebours F; Pierga JY; Guillot E; Santulli P; Grynberg M; Sonigo C; Reyrat E; Soibinet-Oudot P; Reyal F; Hamy AS
Front Oncol; 2021; 11():701620. PubMed ID: 34650912
[TBL] [Abstract][Full Text] [Related]
2. The positive effect of a dedicated adolescent and young adult fertility program on the rates of documentation of therapy-associated infertility risk and fertility preservation options.
Lewin J; Ma JMZ; Mitchell L; Tam S; Puri N; Stephens D; Srikanthan A; Bedard P; Razak A; Crump M; Warr D; Giuliani M; Gupta A
Support Care Cancer; 2017 Jun; 25(6):1915-1922. PubMed ID: 28155019
[TBL] [Abstract][Full Text] [Related]
3. Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer.
Letourneau JM; Sinha N; Wald K; Harris E; Quinn M; Imbar T; Mok-Lin E; Chien AJ; Rosen M
Hum Reprod; 2017 Oct; 32(10):2123-2129. PubMed ID: 28938748
[TBL] [Abstract][Full Text] [Related]
4. Fertility preservation does not delay the initiation of chemotherapy in breast cancer patients treated with adjuvant or neo-adjuvant chemotherapy.
D'Hondt C; Vanhoeij M; Van Moer E; Segers I; Fontaine C; Tournaye H; De Vos M
Breast Cancer Res Treat; 2020 Nov; 184(2):433-444. PubMed ID: 32794060
[TBL] [Abstract][Full Text] [Related]
5. Survey of young women with breast cancer to identify rates of fertility preservation (FP) discussion and barriers to FP care.
Sauerbrun-Cutler MT; Pandya S; Recabo O; Raker C; Clark MA; Robison K
J Assist Reprod Genet; 2023 Aug; 40(8):2003-2011. PubMed ID: 37329421
[TBL] [Abstract][Full Text] [Related]
6. Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation.
Letourneau JM; Wald K; Sinha N; Juarez-Hernandez F; Harris E; Cedars MI; McCulloch CE; Dolezal M; Chien AJ; Rosen MP
Cancer; 2020 Feb; 126(3):487-495. PubMed ID: 31639215
[TBL] [Abstract][Full Text] [Related]
7. Reproductive Outcomes After Breast Cancer in Women With vs Without Fertility Preservation.
Marklund A; Lundberg FE; Eloranta S; Hedayati E; Pettersson K; Rodriguez-Wallberg KA
JAMA Oncol; 2021 Jan; 7(1):86-91. PubMed ID: 33211089
[TBL] [Abstract][Full Text] [Related]
8. Does a dedicated program for young breast cancer patients affect the likelihood of fertility preservation discussion and referral?
Srikanthan A; Amir E; Warner E
Breast; 2016 Jun; 27():22-6. PubMed ID: 27212696
[TBL] [Abstract][Full Text] [Related]
9. Influence of breast cancer prognostic factors on oocyte in vitro maturation outcomes performed for urgent fertility preservation.
Raad J; Sonigo C; Benoit A; Cedrin-Durnerin I; Sifer C; Sermondade N; Grynberg M
Hum Reprod; 2022 Jun; 37(7):1480-1488. PubMed ID: 35586947
[TBL] [Abstract][Full Text] [Related]
10. Decision-making in female fertility preservation is balancing the expected burden of fertility preservation treatment and the wish to conceive.
Baysal Ö; Bastings L; Beerendonk CC; Postma SA; IntHout J; Verhaak CM; Braat DD; Nelen WL
Hum Reprod; 2015 Jul; 30(7):1625-34. PubMed ID: 26034191
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of boys who have undergone a testicular biopsy for fertility preservation.
Kanbar M; de Michele F; Giudice MG; Desmet L; Poels J; Wyns C
Hum Reprod; 2021 Jan; 36(1):26-39. PubMed ID: 33259629
[TBL] [Abstract][Full Text] [Related]
12. Young women with breast cancer: how many are actually candidates for fertility preservation?
Moffat R; de Geyter C; Myrick ME; Schmid SM; Sattmann C; Tschudin S; Kilic N; Güth U
Arch Gynecol Obstet; 2012 Dec; 286(6):1521-7. PubMed ID: 22821507
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study.
Marklund A; Eloranta S; Wikander I; Kitlinski ML; Lood M; Nedstrand E; Thurin-Kjellberg A; Zhang P; Bergh J; Rodriguez-Wallberg KA
Hum Reprod; 2020 Apr; 35(4):929-938. PubMed ID: 32313940
[TBL] [Abstract][Full Text] [Related]
14. Patterns of Referral for Fertility Preservation Among Female Adolescents and Young Adults with Breast Cancer: A Population-Based Study.
Korkidakis A; Lajkosz K; Green M; Strobino D; Velez MP
J Adolesc Young Adult Oncol; 2019 Apr; 8(2):197-204. PubMed ID: 30676852
[TBL] [Abstract][Full Text] [Related]
15. Knowledge, attitudes, and behaviors toward fertility preservation in patients with breast cancer: A cross-sectional survey of physicians.
Baek SY; Lee KH; Kim SB; Gomez H; Vidaurre T; Park YH; Ahn HK; Kim YS; Park IH; Ahn SG; Lee J; Jeong JH; Kim S; Kim HJ
Front Oncol; 2023; 13():1109694. PubMed ID: 36756160
[TBL] [Abstract][Full Text] [Related]
16. Patterns of Fertility Preservation and Pregnancy Outcome After Breast Cancer at a Large Comprehensive Cancer Center.
Dieci MV; Ghiotto C; Barbieri C; Griguolo G; Saccardi C; Gangemi M; Pluchinotta A; Di Liso E; Giorgi CA; Giarratano T; Tasca G; Vernaci G; Faggioni G; Conte P; Guarneri V
J Womens Health (Larchmt); 2019 Apr; 28(4):544-550. PubMed ID: 29963941
[TBL] [Abstract][Full Text] [Related]
17. Relapse Rates and Disease-Specific Mortality Following Procedures for Fertility Preservation at Time of Breast Cancer Diagnosis.
Marklund A; Lekberg T; Hedayati E; Liljegren A; Bergh J; Lundberg FE; Rodriguez-Wallberg KA
JAMA Oncol; 2022 Oct; 8(10):1438-1446. PubMed ID: 36006625
[TBL] [Abstract][Full Text] [Related]
18. Oocyte vitrification for fertility preservation following COS does not delay the initiation of neoadjuvant chemotherapy for breast cancer compared to IVM.
Sellami I; Mayeur A; Benoit A; Zeghari F; Peigné M; Roufael J; Grynberg M; Sonigo C
J Assist Reprod Genet; 2023 Mar; 40(3):473-480. PubMed ID: 36752941
[TBL] [Abstract][Full Text] [Related]
19. Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy.
Chien AJ; Chambers J; Mcauley F; Kaplan T; Letourneau J; Hwang J; Kim MO; Melisko ME; Rugo HS; Esserman LJ; Rosen MP
Breast Cancer Res Treat; 2017 Aug; 165(1):151-159. PubMed ID: 28503722
[TBL] [Abstract][Full Text] [Related]
20. Fertility Preservation in Young Women with Breast Cancer: Impact on Treatment and Outcomes.
Crown A; Muhsen S; Sevilimedu V; Kelvin J; Goldfarb SB; Gemignani ML
Ann Surg Oncol; 2022 Sep; 29(9):5786-5796. PubMed ID: 35672625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
